A detailed history of Strs Ohio transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Strs Ohio holds 8,500 shares of RCUS stock, worth $133,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,500
Previous 6,900 23.19%
Holding current value
$133,450
Previous $105,000 22.86%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$13.69 - $18.01 $21,904 - $28,816
1,600 Added 23.19%
8,500 $129,000
Q2 2024

Aug 05, 2024

BUY
$14.59 - $18.48 $100,671 - $127,512
6,900 New
6,900 $105,000
Q4 2023

Jan 30, 2024

BUY
$13.43 - $19.63 $79,237 - $115,817
5,900 Added 245.83%
8,300 $158,000
Q3 2023

Oct 26, 2023

BUY
$17.62 - $23.54 $42,288 - $56,496
2,400 New
2,400 $43,000
Q1 2023

Aug 02, 2023

BUY
$15.96 - $23.15 $360,696 - $523,189
22,600 New
22,600 $412,000
Q1 2023

Apr 27, 2023

SELL
$15.96 - $23.15 $55,860 - $81,025
-3,500 Reduced 13.41%
22,600 $412,000
Q4 2022

Jan 26, 2023

SELL
$19.7 - $35.71 $128,050 - $232,115
-6,500 Reduced 19.94%
26,100 $539,000
Q3 2022

Oct 27, 2022

SELL
$23.23 - $30.07 $39,491 - $51,119
-1,700 Reduced 4.96%
32,600 $852,000
Q2 2022

Jul 25, 2022

BUY
$17.23 - $37.73 $590,989 - $1.29 Million
34,300 New
34,300 $869,000
Q4 2021

Jan 24, 2022

SELL
$31.38 - $48.47 $514,632 - $794,908
-16,400 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$22.75 - $35.77 $102,375 - $160,965
4,500 Added 37.82%
16,400 $450,000
Q1 2021

Apr 23, 2021

SELL
$26.16 - $41.39 $180,504 - $285,591
-6,900 Reduced 36.7%
11,900 $334,000
Q4 2020

Jan 25, 2021

BUY
$17.0 - $32.36 $102,000 - $194,160
6,000 Added 46.88%
18,800 $488,000
Q3 2020

Dec 14, 2020

SELL
$17.14 - $25.47 $8,570 - $12,735
-500 Reduced 3.76%
12,800 $219,000
Q2 2020

Jul 23, 2020

BUY
$13.97 - $36.56 $185,801 - $486,248
13,300 New
13,300 $329,000
Q4 2018

Jan 23, 2019

SELL
$9.74 - $14.5 $0 - $0
0 Closed
0 $0
Q3 2018

Oct 19, 2018

SELL
$10.88 - $14.95 $16,320 - $22,425
-1,500 Closed
0 $0
Q2 2018

Aug 06, 2018

BUY
$12.24 - $17.05 $18,360 - $25,575
1,500 New
1,500 $18,000

Others Institutions Holding RCUS

About Arcus Biosciences, Inc.


  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.13B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.